Dan Cafaro Email and Phone Number
Principal Consultant
at
Scendea
Dan Cafaro's email is dcafaro@quarkpharma.com
and
Dan Cafaro's phone number is +1510-402-4020
.
Dan Cafaro Contact Details
Email
dcafaro@quarkpharma.com
Email
cafarodaniel@mail2libra.com
Email
d.pcafaro@xoma.com
Email
cafaro@xoma.com
Email
cafaro_dan@allergan.com
Email
d.cafaro@xoma.com
Phone
+1510-402-4020
Dan Cafaro's Experience and Education
Executive Vice President, Regulatory Affairs
2017-02-28 to 2018-12
Fremont, California, United States
Vice President, Regulatory Affairs And Compliance
1996 to 2016-12
Berkeley, California, United States
Instituto La Mennais
University Of California
Instituto La Mennais, Montevideo Uruguay
Unknown to 1975
Instituto La Mennais, Montevideo Uruguay
1975 to Unknown
Bachelor Of Science in Chemistry
1977 to 1980
Los Angeles, California, United States
Los Angeles Valley College
Associates in Chemistry
1975 to 1977
Frequently Asked Questions about Dan Cafaro
What company does Dan Cafaro work for?
Dan Cafaro works for Scendea
What is Dan Cafaro's role in his workplace?
Dan Cafaro's role in his workplace is
Principal Consultant .
Which industry does Dan Cafaro work in currently?
Dan Cafaro works in the industry
Pharmaceuticals.
What is Dan Cafaro's email address?
Dan Cafaro's email address is dcafaro@quarkpharma.com
What is Dan Cafaro's direct phone number?
Dan Cafaro's direct phone number is +1510-402-4020
What schools did Dan Cafaro attended?
Dan Cafaro attended
Instituto La Mennais,
University Of California,
Instituto La Mennais, Montevideo Uruguay,
Instituto La Mennais, Montevideo Uruguay,
University Of California, Los Angeles,
and
Los Angeles Valley College.
What are some of Dan Cafaro's skills?
Dan Cafaro has skills like
U.S. Food And Drug Administration,
Regulatory Affairs,
Pharmaceutical Industry,
Life Sciences,
Clinical Development,
Biopharmaceuticals,
Clinical Trials,
Oncology,
Biotechnology,
Fda,
Capa,
Pharmacovigilance,
Drug Development,
Lifesciences,
R&D,
V&V,
Ind,
Technology Transfer,
Change Control,
Validation,
and
Regulatory Requirements.